Acarbose Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
Condition:   Diabetes Mellitus, Type 2Interventions:   Drug: INSULIN GLARGINE;   Drug: metformin;   Drug: repaglinide;   Drug: acarbose;   Drug: sitagliptinSponsor:   SanofiNot yet recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2016 Category: Research Source Type: clinical trials

Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
< b > Condition < /b > :   Diabetes Mellitus, Type 2 < br/ > < b > Interventions < /b > :   Drug: INSULIN GLARGINE;   Drug: metformin;   Drug: repaglinide;   Drug: acarbose;   Drug: sitagliptin < br/ > < b > Sponsor < /b > :   Sanofi < br/ > < b > Not yet recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2016 Category: Research Source Type: clinical trials

Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
Condition:   Diabetes Mellitus, Type 2Interventions:   Drug: INSULIN GLARGINE;   Drug: metformin;   Drug: repaglinide;   Drug: acarbose;   Drug: sitagliptinSponsor:   SanofiNot yet recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2016 Category: Research Source Type: clinical trials

Acarbose Anti-aging Effects in Geriatric Subjects
Condition:   Aging Intervention:   Drug: acarbose Sponsor:   The University of Texas Health Science Center at San Antonio Recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 17, 2016 Category: Research Source Type: clinical trials